USFDA inspects Unit 1 of Divi's Laboratories Limited

Divi's Laboratories Limited 's Unit-I facility at Lingojigudem Village, Choutuppal Mandal, Yadadri Bhuvanagiri district, Telangana, has been inspected by the US Food and Drug Administration (US-FDA) from November 10, 2025 to November 14, 2025. This inspection was a general cGMP inspection by the US-FDA. The inspection has been concluded with no 483 observations.

Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 6511.40 as compared to the previous close of Rs. 6589.65. The total number of shares traded during the day was 13041 in over 1872 trades.

The stock hit an intraday high of Rs. 6631.65 and intraday low of 6481.20. The net turnover during the day was Rs. 85858165.00.

Source : Equity Bulls

Keywords

DivisLaboratories INE361B01024 Pharmaceuticals USFDA Inspection Unit1